Valence Life Sciences
North America, New York, United States, New York
Description
Valence Life Sciences is the only life sciences venture firm with a proven track record of success in late-stage investing.
Investor Profile
Valence Life Sciences has made 8 investments, with 0 in the past 12 months and 38% as lead.
Stage Focus
- Private Equity (25%)
- Series Unknown (25%)
- Series D (25%)
- Series C (13%)
- Series E (13%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Biotechnology
- Medical Device
- Information Technology
- Life Science
- Manufacturing
- Biopharma
- Health Diagnostics
- Medical
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
